O	0	11	Correlation
O	12	14	of
B-Diagnostic_tool	15	21	fundus
I-Diagnostic_tool	22	38	autofluorescence
O	39	43	with
B-Diagnostic_tool	44	52	spectral
I-Diagnostic_tool	52	53	-
I-Diagnostic_tool	53	59	domain
I-Diagnostic_tool	60	67	optical
I-Diagnostic_tool	68	77	coherence
I-Diagnostic_tool	78	88	tomography
O	89	92	and
O	93	99	vision
O	100	102	in
B-Disease	103	111	diabetic
I-Disease	112	119	macular
I-Disease	120	125	edema
O	125	126	.

O	128	130	To
O	131	142	investigate
O	143	146	the
O	147	158	correlation
O	159	166	between
B-Diagnostic_tool	167	173	fundus
I-Diagnostic_tool	174	190	autofluorescence
O	191	192	(
B-Diagnostic_tool	192	195	FAF
O	195	196	)
O	197	200	and
O	201	204	the
O	205	212	results
O	213	215	of
B-Diagnostic_tool	216	224	spectral
I-Diagnostic_tool	224	225	-
I-Diagnostic_tool	225	231	domain
I-Diagnostic_tool	232	239	optical
I-Diagnostic_tool	240	249	coherence
I-Diagnostic_tool	250	260	tomography
O	261	262	(
B-Diagnostic_tool	262	264	SD
I-Diagnostic_tool	264	265	-
I-Diagnostic_tool	265	268	OCT
O	268	269	)
O	270	272	as
O	273	277	well
O	278	280	as
B-Diagnostic_tool	281	287	visual
I-Diagnostic_tool	288	294	acuity
O	295	296	(
B-Diagnostic_tool	296	298	VA
O	298	299	)
O	300	302	in
O	303	311	patients
O	312	316	with
B-Disease	317	325	diabetic
I-Disease	326	333	macular
I-Disease	334	339	edema
O	340	341	(
B-Disease	341	344	DME
O	344	345	)
O	346	349	and
O	350	352	to
O	353	362	determine
O	363	366	the
O	367	373	visual
O	374	384	prognostic
O	385	392	factors
O	392	393	.

O	394	407	Retrospective
O	407	408	,
O	409	423	interventional
O	424	428	case
O	429	435	series
O	435	436	.

O	437	442	Sixty
O	442	443	-
O	443	446	one
O	447	455	patients
O	456	460	with
B-Disease	461	464	DME
O	465	468	who
O	469	478	underwent
O	479	491	intravitreal
O	492	501	injection
O	502	504	of
O	505	516	bevacizumab
O	517	518	(
O	518	521	IVB
O	521	522	)
O	523	525	as
O	526	531	their
O	532	537	first
O	538	547	treatment
O	547	548	.

O	549	551	An
O	552	562	assessment
O	563	565	of
B-Diagnostic_tool	566	568	VA
O	569	572	and
B-Diagnostic_tool	573	576	FAF
O	577	580	and
B-Diagnostic_tool	581	583	SD
I-Diagnostic_tool	583	584	-
I-Diagnostic_tool	584	587	OCT
O	588	594	images
O	595	599	were
O	600	608	obtained
O	609	615	before
O	616	619	and
O	620	625	after
O	626	629	IVB
O	630	631	(
O	631	634	pre
O	634	635	-
O	636	639	and
O	640	644	post
O	644	645	-
O	645	648	IVB
O	648	649	)
O	649	650	.

B-Diagnostic_tool	651	657	Foveal
I-Diagnostic_tool	658	661	FAF
O	662	665	was
O	666	672	graded
O	673	675	on
O	676	677	a
O	678	683	scale
O	684	686	of
O	687	688	1
O	689	691	to
O	692	693	4
O	693	694	.

O	695	698	The
O	699	707	presence
O	708	710	or
O	711	718	absence
O	719	721	of
B-Diagnostic_tool	722	725	FAF
O	726	728	at
O	729	732	the
B-Anatomy	733	740	foveola
O	741	744	was
O	745	749	also
O	750	760	determined
O	760	761	.

O	762	765	The
O	766	777	association
O	778	780	of
B-Diagnostic_tool	781	784	FAF
O	785	789	with
B-Diagnostic_tool	790	792	VA
O	793	796	and
O	797	800	the
B-Diagnostic_tool	801	803	SD
I-Diagnostic_tool	803	804	-
I-Diagnostic_tool	804	807	OCT
O	808	815	results
O	815	816	,
O	817	826	including
B-Characteristic	827	834	central
I-Characteristic	835	842	macular
I-Characteristic	843	852	thickness
O	853	854	(
B-Characteristic	854	857	CMT
O	857	858	)
O	858	859	,
B-Characteristic	860	865	outer
I-Characteristic	866	873	nuclear
I-Characteristic	874	879	layer
I-Characteristic	880	889	thickness
O	889	890	,
O	891	894	the
B-Characteristic	895	904	integrity
I-Characteristic	905	907	of
I-Characteristic	908	911	the
I-Characteristic	912	920	external
I-Characteristic	921	929	limiting
I-Characteristic	930	938	membrane
O	939	940	(
B-Anatomy	940	943	ELM
O	943	944	)
O	944	945	,
O	946	949	and
O	950	953	the
B-Characteristic	954	963	integrity
I-Characteristic	964	966	of
I-Characteristic	967	970	the
I-Characteristic	971	979	junction
I-Characteristic	980	987	between
I-Characteristic	988	991	the
I-Characteristic	992	997	inner
I-Characteristic	998	1001	and
I-Characteristic	1002	1007	outer
I-Characteristic	1008	1015	segment
I-Characteristic	1016	1018	of
I-Characteristic	1019	1022	the
I-Characteristic	1023	1036	photoreceptor
O	1037	1038	(
B-Anatomy	1038	1040	IS
I-Anatomy	1040	1041	/
I-Anatomy	1041	1043	OS
O	1043	1044	)
O	1044	1045	.

B-Characteristic	1046	1052	Better
I-Characteristic	1053	1055	VA
O	1055	1056	,
B-Characteristic	1057	1069	preservation
I-Characteristic	1070	1072	of
I-Characteristic	1073	1076	the
I-Characteristic	1077	1080	ELM
I-Characteristic	1080	1081	,
I-Characteristic	1082	1085	and
I-Characteristic	1086	1088	IS
I-Characteristic	1088	1089	/
I-Characteristic	1089	1091	OS
O	1092	1095	pre
O	1095	1096	-
O	1096	1099	IVB
O	1100	1104	were
O	1105	1115	associated
O	1116	1120	with
B-Characteristic	1121	1127	better
I-Characteristic	1128	1130	VA
O	1131	1135	post
O	1135	1136	-
O	1136	1139	IVB
O	1139	1140	.

O	1141	1143	Of
O	1144	1147	the
O	1148	1153	types
O	1154	1156	of
B-Disease	1157	1160	DME
O	1160	1161	,
B-Disease	1162	1169	cystoid
I-Disease	1170	1177	macular
I-Disease	1178	1183	edema
O	1184	1197	significantly
O	1198	1208	correlated
O	1209	1213	with
B-Symptom	1214	1223	increased
I-Symptom	1224	1227	FAF
O	1228	1230	at
O	1231	1234	the
B-Anatomy	1235	1242	foveola
O	1242	1243	.

O	1244	1245	A
B-Symptom	1246	1252	higher
I-Symptom	1253	1258	level
I-Symptom	1259	1261	of
I-Symptom	1262	1265	FAF
O	1266	1269	was
O	1270	1271	5
O	1271	1272	.
O	1272	1273	6
O	1274	1279	times
O	1280	1284	more
O	1285	1291	likely
O	1292	1294	to
O	1295	1300	occur
O	1301	1303	in
B-Disease	1304	1307	DME
O	1308	1312	with
O	1313	1314	a
B-Symptom	1315	1321	defect
I-Symptom	1322	1324	in
I-Symptom	1325	1327	IS
I-Symptom	1327	1328	/
I-Symptom	1328	1330	OS
O	1331	1334	and
O	1335	1337	10
O	1338	1343	times
O	1344	1348	more
O	1349	1355	likely
O	1356	1358	to
O	1359	1364	occur
O	1365	1369	with
O	1370	1374	each
B-Dimension	1375	1377	10
I-Dimension	1377	1378	-
I-Dimension	1378	1379	Î¼
I-Dimension	1379	1380	m
O	1381	1389	increase
O	1390	1392	in
B-Characteristic	1393	1396	CMT
O	1396	1397	.

O	1398	1402	Each
O	1403	1411	increase
O	1412	1414	by
O	1415	1416	a
O	1417	1423	factor
O	1424	1426	of
O	1427	1428	0
O	1428	1429	.
O	1429	1430	1
O	1431	1433	in
O	1434	1437	the
B-Characteristic	1438	1447	logarithm
I-Characteristic	1448	1450	of
I-Characteristic	1451	1454	the
I-Characteristic	1455	1462	minimum
I-Characteristic	1463	1468	angle
I-Characteristic	1469	1471	of
I-Characteristic	1472	1482	resolution
O	1483	1484	(
B-Characteristic	1484	1490	logMAR
O	1490	1491	)
O	1492	1495	pre
O	1495	1496	-
O	1496	1499	IVB
O	1500	1509	increased
O	1510	1513	the
O	1514	1525	probability
O	1526	1528	of
B-Symptom	1529	1533	high
I-Symptom	1534	1537	FAF
O	1538	1540	by
O	1541	1542	a
O	1543	1549	factor
O	1550	1552	of
O	1553	1554	1
O	1554	1555	.
O	1555	1557	73
O	1557	1558	.

O	1559	1566	Despite
B-Disease	1567	1573	severe
I-Disease	1574	1577	DME
O	1577	1578	,
O	1579	1584	fewer
B-Anatomy	1585	1589	eyes
O	1590	1594	with
O	1595	1596	a
B-Symptom	1597	1600	low
I-Symptom	1601	1606	level
I-Symptom	1607	1609	of
I-Symptom	1610	1613	FAF
O	1614	1623	exhibited
O	1624	1626	an
B-Symptom	1627	1629	IS
I-Symptom	1629	1630	/
I-Symptom	1630	1632	OS
I-Symptom	1633	1639	defect
O	1640	1643	and
B-Symptom	1644	1649	large
I-Symptom	1650	1656	logMAR
I-Symptom	1657	1659	VA
O	1660	1664	than
B-Anatomy	1665	1669	eyes
O	1670	1674	with
O	1675	1676	a
B-Symptom	1677	1681	high
I-Symptom	1682	1687	level
I-Symptom	1688	1690	of
I-Symptom	1691	1694	FAF
O	1695	1699	with
B-Disease	1700	1706	severe
I-Disease	1707	1710	DME
O	1711	1714	pre
O	1714	1715	-
O	1715	1718	IVB
O	1718	1719	.

O	1720	1723	The
B-Characteristic	1724	1731	average
I-Characteristic	1732	1737	grade
I-Characteristic	1738	1740	of
I-Characteristic	1741	1744	FAF
O	1745	1748	pre
O	1748	1749	-
O	1749	1752	IVB
O	1753	1756	was
O	1757	1763	higher
O	1764	1766	in
O	1767	1775	patients
O	1776	1780	with
B-Symptom	1781	1790	decreased
I-Symptom	1791	1797	vision
O	1798	1804	during
O	1805	1811	follow
O	1811	1812	-
O	1812	1814	up
O	1815	1819	than
O	1820	1822	in
O	1823	1831	patients
O	1832	1836	with
O	1837	1846	increased
O	1847	1849	or
O	1850	1859	unchanged
B-Characteristic	1860	1864	good
I-Characteristic	1865	1871	vision
O	1871	1872	.

O	1873	1876	The
O	1877	1883	strong
O	1884	1895	association
O	1896	1898	of
B-Diagnostic_tool	1899	1902	FAF
O	1903	1907	with
B-Diagnostic_tool	1908	1910	SD
I-Diagnostic_tool	1910	1911	-
I-Diagnostic_tool	1911	1914	OCT
O	1915	1925	parameters
O	1926	1929	and
B-Diagnostic_tool	1930	1932	VA
O	1933	1935	in
O	1936	1944	patients
O	1945	1949	with
B-Disease	1950	1953	DME
O	1954	1959	could
O	1960	1963	aid
O	1964	1966	in
O	1967	1970	the
O	1971	1981	prediction
O	1982	1984	of
O	1985	1988	the
O	1989	2000	restoration
O	2001	2003	of
B-Characteristic	2004	2017	photoreceptor
I-Characteristic	2018	2027	integrity
O	2028	2031	and
O	2032	2042	subsequent
O	2043	2049	visual
O	2050	2058	recovery
O	2058	2059	,
O	2060	2070	especially
O	2071	2073	in
O	2074	2082	patients
O	2083	2087	with
B-Disease	2088	2094	severe
I-Disease	2095	2098	DME
O	2098	2099	,
O	2100	2102	in
O	2103	2107	whom
B-Characteristic	2108	2121	photoreceptor
I-Characteristic	2122	2131	integrity
O	2132	2138	before
O	2139	2148	treatment
O	2149	2154	could
O	2155	2158	not
O	2159	2161	be
O	2162	2172	adequately
O	2173	2182	evaluated
O	2182	2183	,
O	2184	2188	even
O	2189	2193	with
B-Diagnostic_tool	2194	2196	SD
I-Diagnostic_tool	2196	2197	-
I-Diagnostic_tool	2197	2200	OCT
O	2200	2201	.
